Chelation therapy is a highly effective treatment for clearing toxic heavy metals from the body. Although EDTA (ethylenediamine tetraacetic acid), an intravenous chelating agent, was first used to treat lead poisoning, it has since proven to be invaluable for the treatment of heart disease and other conditions involving poor circulation. Along with EDTA, we use additional chelating agents to treat patients who have high levels of mercury.
When EDTA is infused into the bloodstream, it latches onto harmful heavy metals such as lead, iron, and cadmium and carries them out of the body through the urine. By reducing the body’s toxic metal and free radical burden, EDTA improves the health of the arteries and slows the process of atherosclerosis. As an added benefit, it has blood-thinning effects and discourages the formation of potentially dangerous blood clots that can cause a heart attack or stroke.
Another heavy metal of particular concern in today’s world is mercury. Mercury is a neurotoxin that also damages the kidneys, red blood cells, and immune cells. It is especially harmful for fetuses and children, and exposure can cause developmental delays and neurological impairment. However, mercury is also linked with a broad range of symptoms in people of all ages.